1 | 10-mg dose of E5501 cyclodextrin oral solution | - | - | - | - | 1件: 63 63 |
2 | 10-mg dose of E5501 lipid-based oral | - | - | - | - | 1件: 63 63 |
3 | 14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration | - | - | - | - | 3件: 13 13, 96, 97 |
4 | 2% Chlorhexidine solution wipes (Synonym: MAJOR ORAL RINSE) | 1件: Chlorhexidine Chlorhexidine (Synonym: QCare Rx Petite Oral Cleansing and Suctioning System) | 4件: D00858
D00858
(Name: MAJOR ORAL RINSE),
D01345
,
D03463
,
D07668
| - | - | 1件: 299 299 |
5 | 20 mg sildenafil citrate by mouth (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
6 | 4% chlorhexidine gluconate liquid skin cleanser (Synonym: MAJOR ORAL RINSE) | 1件: Chlorhexidine Chlorhexidine (Synonym: QCare Rx Petite Oral Cleansing and Suctioning System) | 4件: D00858
D00858
(Name: MAJOR ORAL RINSE),
D01345
,
D03463
,
D07668
| - | - | 1件: 299 299 |
7 | 5% sildenafil cream (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 50 50 |
8 | 750 mg metformin and 7.5 g L-citrulline daily p.o. (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 2件: Citrulline Citrulline, Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 3件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
,
D07706
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 |
9 | A novel synthetic, orally-administered, non-peptide small molecule, which acts as | - | - | - | - | 1件: 254 254 |
10 | A novel synthetic, orally-administered, non-peptide small molecule, which acts as an agonist of the melanocortin-1 receptor (MC1R) | - | - | - | - | 1件: 51 51 |
11 | Access program - sildenafil citrate, Viagra, Revatio (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
12 | Acetohydroxamic Acid Oral Tablet [Lithostat] | 1件: Acetohydroxamic acid Acetohydroxamic acid | 1件: D00220
D00220
| - | - | 1件: 251 251 |
13 | ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
14 | ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 |
15 | ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 |
16 | ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 |
17 | ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 |
18 | All subjects will receive maraviroc 300mg orally twice a day for 6 weeks | 1件: Maraviroc Maraviroc | 1件: D06670
D06670
| 1件: CCR5 CCR5 💬 | 9件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 84 84 |
19 | Alvelestat oral tablet - dose 1 | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 |
20 | Alvelestat oral tablet - dose 2 | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 |
21 | Amifampridine Phosphate 10 MG Oral Tablet | 2件: Amifampridine Amifampridine, Phosphate ion | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 3 3 |
22 | AMT-101 (oral) | - | - | - | - | 1件: 97 97 |
23 | ANAVEX2-73 oral liquid | - | - | - | - | 1件: 156 156 |
24 | Antihistamine (cetirizine or equivalent) (Synonym: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION) | 1件: Cetirizine Cetirizine (Synonym: Cetirizine Hydrochloride Oral Solution) | 2件: D00664
D00664
(Name: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION),
D07662
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 |
25 | Artesunate Oral Product | 1件: Artesunate Artesunate | 1件: D02482
D02482
| - | - | 1件: 18 18 |
26 | Aspirin 650mg Oral Capsule | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
27 | ATOVAQUONE (Synonym: ATOVAQUONE ORAL SUSPENSION) | 1件: Atovaquone Atovaquone (Synonym: Atovaquone Oral Suspension) | 1件: D00236
D00236
(Name: ATOVAQUONE ORAL SUSPENSION) | - | - | 1件: 61 61 |
28 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA | 1件: Teriflunomide Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 |
29 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE | 1件: Teriflunomide Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 |
30 | AZD4017 and prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 |
31 | AZP2006 oral solution | - | - | - | - | 1件: 5 5 |
32 | Bardoxolone methyl oral capsule | 2件: Bardoxolone Bardoxolone, Bardoxolone methyl | 2件: D09584
D09584
,
D09585
| - | - | 1件: 67 67 |
33 | Baricitinib Oral Tablet [Olumiant] | 1件: Baricitinib Baricitinib | 1件: D10308
D10308
| 2件: JAK1 JAK1, JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 |
34 | Bezafibrate 200 MG Oral Tablet | 1件: Bezafibrate Bezafibrate | 1件: D01366
D01366
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 |
35 | Bladder instillation WITH triamcinolone acetonide (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 226 226 |
36 | Bladder instillation WITHOUT triamcinolone acetonide (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 226 226 |
37 | BMS-986256 (Oral) | 1件: Afimetoran Afimetoran | 1件: D11908
D11908
| - | - | 1件: 49 49 |
38 | Bosentan and Sildenafil (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 2件: Bosentan Bosentan, Sildenafil (Synonym: Sildenafil for Oral Suspension) | 4件: D01227
D01227
,
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D07538
,
D08514
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
39 | Budesonide oral suspension | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
40 | Budesonide oral suspension [0.2 mg/ml] | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
41 | Bupivacaine, triamcinolone, and heparin (BTH) (Synonym: ORALONE) | 3件: Bupivacaine Bupivacaine, Heparin, Triamcinolone (Synonym: Oralone) | 8件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D01450
,
D06216
,
D07510
,
D07552
| 7件: NR3C1 NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 | 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction 💬 | 1件: 226 226 |
42 | Cannabidiol Oral Solution | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 4件: 140 140, 144, 145, 193 |
43 | Cannabidiol Oral Solution, is known as Epidyolex 100 mg/mL oral solution and is the approved name in the EU. Epidiolex (cannabidiol) oral solution is the approved name in the US. | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 158 158 |
44 | Carbidopa 200mg oral dose | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
45 | Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
46 | CBD - Oral Solution, is known as Epidiolex, and is the approved name in the USA. | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 140 140, 144 |
47 | CBD - Oral Solution, is known as Epidyolex 100 mg/ml oral solution, | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 158 158 |
48 | CBD - Oral Solution, is known as Epidyolex, and is the approved name | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 |
49 | CBD - Solution Orale, conosciuto come Epidiolex, questo è il nome approvato negli Stati Uniti | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 |
50 | CBD Oral solution, is known as Epidyolex and is the approved name in the EU | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 |
51 | CBD soluzione orale nota come Epidyolex e con tale nome è stato approvato in UE | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 |
52 | CBD-Oral Solution, is known as Epidiolex, and is the approved name in the USA. | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 158 158 |
53 | Celiac Block with triamcinolone and bupivicaine (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 298 298 |
54 | Cephalexin (Synonym: CEPHALEXIN ORAL SUSP) | 1件: Cephalexin Cephalexin (Synonym: Cephalexin Oral Susp) | 2件: D00263
D00263
,
D00906
(Name: CEPHALEXIN ORAL SUSP) | - | - | 1件: 299 299 |
55 | Cetirizine (Synonym: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION) | 1件: Cetirizine Cetirizine (Synonym: Cetirizine Hydrochloride Oral Solution) | 2件: D00664
D00664
(Name: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION),
D07662
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 35 |
56 | CETIRIZINE HYDROCHLORIDE (Synonym: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION) | 1件: Cetirizine Cetirizine (Synonym: Cetirizine Hydrochloride Oral Solution) | 2件: D00664
D00664
(Name: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION),
D07662
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
57 | Chlorhexidine (Synonym: MAJOR ORAL RINSE) | 1件: Chlorhexidine Chlorhexidine (Synonym: QCare Rx Petite Oral Cleansing and Suctioning System) | 4件: D00858
D00858
(Name: MAJOR ORAL RINSE),
D01345
,
D03463
,
D07668
| - | - | 2件: 86 86, 299 |
58 | Chlorhexidine Gluconate (Synonym: MAJOR ORAL RINSE) | 1件: Chlorhexidine Chlorhexidine (Synonym: QCare Rx Petite Oral Cleansing and Suctioning System) | 4件: D00858
D00858
(Name: MAJOR ORAL RINSE),
D01345
,
D03463
,
D07668
| - | - | 1件: 299 299 |
59 | Chlorhexidine gluconate oral rinse | 1件: Chlorhexidine Chlorhexidine (Synonym: QCare Rx Petite Oral Cleansing and Suctioning System) | 4件: D00858
D00858
(Name: MAJOR ORAL RINSE),
D01345
,
D03463
,
D07668
| - | - | 1件: 299 299 |
60 | Cholecalciferol 15000 UNT/ML Oral Solution | 1件: Cholecalciferol Cholecalciferol (Synonym: Vitamin D3 Oral Solution) | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 75 75 |
61 | CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE | 1件: Tadalafil Tadalafil | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 75 75 |
62 | Cladribina oral | 1件: Cladribine Cladribine | 1件: D01370
D01370
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 |
63 | Cladribine Oral Tablet | 1件: Cladribine Cladribine | 1件: D01370
D01370
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 |
64 | Cohort 1:Nilotinib Oral Capsules (150mg or 300mg) | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 |
65 | Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1) | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 |
66 | Colchicine 1 MG Oral Tablet | 1件: Colchicine Colchicine | 1件: D00570
D00570
| 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 |
67 | Combination Oral Budesonide and Rectal Hydrocortisone | 2件: Budesonide Budesonide, Hydrocortisone | 2件: D00088
D00088
,
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
68 | Combination Product: continuous oral delivery of levodopa/carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
69 | Combination therapy with vigabatrin and prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Prednisolone Prednisolone, Vigabatrin (Synonym: Vigabatrin for Oral Solution) | 9件: D00472
D00472
,
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION),
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 2件: ABAT ABAT, NR3C1 💬 | 8件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 145 145 |
70 | Comparator: naproxen tablet 500 mg (Synonym: NAPROXEN ORAL SUSPENSION) | 1件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension) | 1件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION) | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
71 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 7件: Acetate Acetate, Cortisone, Cortisone acetate, Dexamethasone, Hydrocortisone, Prednisolone, Prednisone | 21件: D00088
D00088
,
D00292
,
D00472
,
D00473
,
D00973
,
D00975
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01510
,
D01615
,
D01632
,
D01948
,
D01998
,
D02156
,
D02174
,
D02591
,
D02592
,
D03301
,
D07749
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
72 | Corticosteroid (prednisolone) (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 |
73 | Corticosteroid treatment (Methylprednisolone or prednisolone) (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Methylprednisolone Methylprednisolone, Prednisolone | 14件: D00407
D00407
,
D00472
,
D00751
,
D00979
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 64 64 |
74 | Corticosteroids (prednisone or prednisolone) (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Prednisolone Prednisolone, Prednisone | 9件: D00472
D00472
,
D00473
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 |
75 | Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin (Synonym: VIGABATRIN FOR ORAL SOLUTION) | 2件: Tetracosactide Tetracosactide, Vigabatrin (Synonym: Vigabatrin for Oral Solution) | 2件: D00284
D00284
,
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION) | 2件: ABAT ABAT, MC2R 💬 | 12件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬 | 1件: 145 145 |
76 | Cultivated oral mucosal epithelial sheet transplantation | - | - | - | - | 2件: 38 38, 162 |
77 | CX-4945 oral formulation | - | - | - | - | 1件: 331 331 |
78 | Cyclophosphamide 50Mg Oral Tablet | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
,
D07760
| - | - | 1件: 162 162 |
79 | Cyclosporine Oral Product | 1件: Cyclosporine Cyclosporine (Synonym: Sandimmune Oral Sol 100mg/ml) | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 |
80 | Deferasirox (Synonym: DEFERASIROX ORAL GRANULES) | 1件: Deferasirox Deferasirox (Synonym: Deferasirox Oral Granules) | 1件: D03669
D03669
(Name: DEFERASIROX ORAL GRANULES) | - | - | 3件: 254 254, 284, 286 |
81 | Deferiprone 80 mg/mL oral solution | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
82 | Deferiprone 80 mg/mL oral solution (Ferriprox) | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
83 | Deferiprone oral solution | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
84 | Desloratadine given orally | 1件: Desloratadine Desloratadine | 1件: D03693
D03693
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
85 | Desmopressin Oral Melt | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 72 72 |
86 | Deutetrabenazine Oral Tablet [Austedo] | 1件: Deutetrabenazine Deutetrabenazine | 1件: D10701
D10701
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
87 | Dexamethasone given orally | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
88 | Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland). | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 235 235 |
89 | Diagnostic Test: Oral glucose tolerance test | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 3件: 13 13, 65, 299 |
90 | Dolutegravir / Lamivudine Oral Tablet | 2件: Dolutegravir Dolutegravir, Lamivudine (Synonym: Lamivudine Oral Solution) | 2件: D00353
D00353
,
D10066
| - | - | 1件: 265 265 |
91 | Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO] | 2件: Dolutegravir Dolutegravir, Lamivudine (Synonym: Lamivudine Oral Solution) | 2件: D00353
D00353
,
D10066
| - | - | 1件: 265 265 |
92 | Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO] | 4件: Doravirine Doravirine, Lamivudine (Synonym: Lamivudine Oral Solution), Tenofovir, Tenofovir disoproxil | 4件: D00353
D00353
,
D01982
,
D06074
,
D10624
| - | - | 1件: 265 265 |
93 | Dronabinol 25 mg/ml, oral drops | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 |
94 | Duo-Therapy with Sildenafil + Bosentan (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 2件: Bosentan Bosentan, Sildenafil (Synonym: Sildenafil for Oral Suspension) | 4件: D01227
D01227
,
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D07538
,
D08514
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
95 | E5501 40 mg 2 x 20-mg tablets, orally, fasted | - | - | - | - | 1件: 63 63 |
96 | E5501 40 mg 2 x 20-mg tablets, orally, with food | - | - | - | - | 1件: 63 63 |
97 | E5501 40mg 2 x 20-mg tablets, orally, fasted | - | - | - | - | 1件: 63 63 |
98 | Eliglustat Tartrate – Powder for Oral Suspension | 1件: Eliglustat Eliglustat | 1件: D09893
D09893
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
99 | Eltrombopag oral tablets | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 63 63 |
100 | Enalapril (Synonym: ENALAPRIL MALEATE ORAL SOLUTION) | 1件: Enalapril Enalapril (Synonym: Enalapril maleate oral solution) | 2件: D00621
D00621
(Name: ENALAPRIL MALEATE ORAL SOLUTION),
D07892
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 6件: 19 19, 46, 66, 113, 210, 222 |
101 | Enalapril and other angiotensin converting enzyme inhibitors (Synonym: ENALAPRIL MALEATE ORAL SOLUTION) | 2件: Angiotensin II Angiotensin II, Enalapril (Synonym: Enalapril maleate oral solution) | 4件: D00150
D00150
,
D00621
(Name: ENALAPRIL MALEATE ORAL SOLUTION),
D02014
,
D07892
| 3件: ACE ACE, AGTR1, AGTR2 💬 | 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 19 19 |
102 | Enalapril Maleate (Synonym: ENALAPRIL MALEATE ORAL SOLUTION) | 1件: Enalapril Enalapril (Synonym: Enalapril maleate oral solution) | 2件: D00621
D00621
(Name: ENALAPRIL MALEATE ORAL SOLUTION),
D07892
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 46 46 |
103 | ENALAPRIL VALSARTAN METHYLPREDNISONE (Synonym: ENALAPRIL MALEATE ORAL SOLUTION) | 3件: Enalapril Enalapril (Synonym: Enalapril maleate oral solution), Methylprednisone, Valsartan | 3件: D00400
D00400
,
D00621
(Name: ENALAPRIL MALEATE ORAL SOLUTION),
D07892
| 2件: ACE ACE, AGTR1 💬 | 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 |
104 | Entacapone 400mg oral dose | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
105 | EnteraBio's Oral Parathyroid Hormone (1-34) | 1件: Parathyroid hormone Parathyroid hormone | 1件: D05364
D05364
| 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 |
106 | ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan) (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 4件: Bosentan Bosentan, Macitentan, Sildenafil (Synonym: Sildenafil for Oral Suspension), Tadalafil | 6件: D01227
D01227
,
D02008
,
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D07538
,
D08514
,
D10135
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
107 | Erythrocine oral | - | - | - | - | 1件: 36 36 |
108 | ESBRIET - 267 MG - CAPSULA RIGIDA - USO ORALE - FLACONE (HDPE) 270 CAPSULE | 1件: Pirfenidone Pirfenidone | 1件: D01583
D01583
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | 84件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 |
109 | Etanercept, Methotrexate, Prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 3件: Etanercept Etanercept, Methotrexate, Prednisolone | 11件: D00142
D00142
,
D00472
,
D00742
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02115
,
D02156
,
D03301
| 5件: DHFR DHFR, DHFR2, LTA, NR3C1, TNF 💬 | 72件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 56 56 |
110 | Everolimus Oral Product | 1件: Everolimus Everolimus | 1件: D02714
D02714
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 2件: 89 89, 158 |
111 | FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14) | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
112 | Fentanyl (Synonym: Oralet (TN)) | 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
(Name: Oralet (TN)) | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 4件: 46 46, 70, 215, 231 |
113 | Fentanyl (High Dose) (Synonym: Oralet (TN)) | 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
(Name: Oralet (TN)) | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 215 215 |
114 | Fentanyl (Low Dose) (Synonym: Oralet (TN)) | 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
(Name: Oralet (TN)) | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 215 215 |
115 | Fentanyl (Low Dose) + Dexmedetomidine (Synonym: Oralet (TN)) | 2件: Dexmedetomidine Dexmedetomidine, Fentanyl | 4件: D00320
D00320
,
D00514
,
D01205
,
D01399
(Name: Oralet (TN)) | 4件: ADRA2A ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 | 4件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 |
116 | Fentanyl transdermal patch (Synonym: Oralet (TN)) | 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
(Name: Oralet (TN)) | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
117 | Ferrous sulphate 200mg oral tablet | - | - | - | - | 1件: 227 227 |
118 | Fipamezole hydrochloride 30 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
119 | Fipamezole hydrochloride 60 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
120 | Fipamezole hydrochloride 90 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
121 | FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE | 1件: Amifampridine Amifampridine | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 3 3, 11 |
122 | Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution | 1件: Flucloxacillin Flucloxacillin | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
123 | FLX-787-ODT (orally disintegrating tablet) | - | - | - | - | 1件: 10 10 |
124 | FLX-787-ODT (orally disintigrating tablet) | - | - | - | - | 1件: 2 2 |
125 | FMT oral | - | - | - | - | 1件: 97 97 |
126 | Frequently Sampled Oral Glucose Tolerance Test and CGM | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
127 | G04BE03- Sildenafil - sildenafil (citrato) (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
128 | GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
129 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
130 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
131 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
132 | Glatiramer acetate injection with oral cetirizine hydrochloride | 3件: Acetate Acetate, Cetirizine (Synonym: Cetirizine Hydrochloride Oral Solution), Glatiramer | 3件: D00664
D00664
(Name: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION),
D04318
,
D07662
| 21件: HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, HRH1 💬 | 35件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 |
133 | GLPG0259 oral capsule | - | - | - | - | 1件: 46 46 |
134 | Glucocorticoid (prednisone or prednisolone) (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Prednisolone Prednisolone, Prednisone | 9件: D00472
D00472
,
D00473
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
135 | Glucophage (metformin) (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 2件: 46 46, 75 |
136 | Home Oral Glucose Tolerance Test kit | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
137 | IDL-2965 Oral Capsule | - | - | - | - | 1件: 85 85 |
138 | INS1007 10 mg oral tablet | - | - | - | - | 1件: 299 299 |
139 | INS1007 25 mg oral tablet | - | - | - | - | 1件: 299 299 |
140 | INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE | 1件: Etravirine Etravirine | 1件: D04112
D04112
| - | - | 1件: 18 18 |
141 | Interferon alpha oral lozenge | - | - | - | - | 1件: 85 85 |
142 | Interferon beta 1a, oral doxycycline | 3件: Doxycycline Doxycycline, Human interferon beta, Interferon beta-1a | 6件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D04554
,
D07876
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
143 | Intra Plexus Triamcinolone and Bupivicaine Injection (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 298 298 |
144 | Intravenous and Oral n-acetyl cysteine | 1件: Cysteine Cysteine | 2件: D00026
D00026
,
D02326
| - | - | 1件: 6 6 |
145 | Intravenous methyl prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 43 43 |
146 | Iohexol (Synonym: ORALTAG) | 1件: Iohexol Iohexol (Synonym: Oraltag) | 1件: D01817
D01817
(Name: ORALTAG) | - | - | 2件: 19 19, 67 |
147 | Iohexol Inj 300 milligrams per milliliter (MG/ML) (Synonym: ORALTAG) | 1件: Iohexol Iohexol (Synonym: Oraltag) | 1件: D01817
D01817
(Name: ORALTAG) | - | - | 1件: 67 67 |
148 | Iowa Oral Performance Instrument | - | - | - | - | 1件: 2 2 |
149 | Iowa Oral Pressure Instrument | - | - | - | - | 1件: 2 2 |
150 | Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally. | 2件: Itraconazole Itraconazole (Synonym: Sporanox Oral Solution 10mg/ml), Terbinafine | 3件: D00350
D00350
,
D02219
,
D02375
| - | - | 1件: 96 96 |
151 | JINARC - 15 MG +45 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28X15 MG + 28 X 45 MG) | 1件: Tolvaptan Tolvaptan | 1件: D01213
D01213
| 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 |
152 | JINARC - 15 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE | 1件: Tolvaptan Tolvaptan | 1件: D01213
D01213
| 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 |
153 | JINARC - 30 MG + 60 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 60 MG) | 1件: Tolvaptan Tolvaptan | 1件: D01213
D01213
| 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 |
154 | JINARC - 30 MG +90 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 90 MG) | 1件: Tolvaptan Tolvaptan | 1件: D01213
D01213
| 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 |
155 | JINARC - 30 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE | 1件: Tolvaptan Tolvaptan | 1件: D01213
D01213
| 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 |
156 | L-Citrulline and Metformin & L-Citrulline (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 2件: Citrulline Citrulline, Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 3件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
,
D07706
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 |
157 | Lamotrigine 25Mg Oral Tablet, Extended Release | 1件: Lamotrigine Lamotrigine | 1件: D00354
D00354
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 114 114 |
158 | Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP (Synonym: ORALONE) | 5件: Dapsone Dapsone, Mycophenolate mofetil, Mycophenolic acid, Prednisolone, Triamcinolone (Synonym: Oralone) | 18件: D00385
D00385
,
D00472
,
D00592
,
D00752
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D01239
,
D01998
,
D02156
,
D03301
,
D05094
,
D05095
,
D05096
,
D06216
| 3件: IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | 1件: 162 162 |
159 | Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
160 | Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
161 | Liprotamase Powder for Oral Solution | - | - | - | - | 1件: 299 299 |
162 | Lo-Ovral Oral Contraceptive Pills | - | - | - | - | 1件: 60 60 |
163 | Lodotra (delayed release prednisolone) (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 |
164 | Long-circulating liposomal prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
165 | Low dose prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
166 | MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE | 1件: Cladribine Cladribine | 1件: D01370
D01370
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 |
167 | Maximal oral 5ASA | - | - | - | - | 1件: 97 97 |
168 | Medium dose prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
169 | Megadose oral methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
170 | Meloxicam oral suspension | 1件: Meloxicam Meloxicam | 1件: D00969
D00969
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
171 | Memantine Hydrochloride Oral Solution | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 2 2 |
172 | Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet | 2件: Mesalazine Mesalazine, Nitazoxanide | 2件: D00377
D00377
,
D02486
| - | - | 1件: 97 97 |
173 | Metformin (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 24件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
174 | Metformin (generic) (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 158 158 |
175 | Metformin 500 mg TID Oral Tablet | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 97 97 |
176 | Metformin 500mg (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 |
177 | Metformin and Metformin & L-Citrulline (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 2件: Citrulline Citrulline, Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 3件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
,
D07706
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 |
178 | Metformin HCl (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 285 285 |
179 | METFORMIN HYDROCHLORIDE (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 5件: 81 81, 158, 265, 299, 301 |
180 | Metformin treatment (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 46 46 |
181 | Metformin XR (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 67 67 |
182 | Metformin/CP-690,550 (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 46 46 |
183 | Methotrexate - etanercept - prednisolone arm (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 3件: Etanercept Etanercept, Methotrexate, Prednisolone | 11件: D00142
D00142
,
D00472
,
D00742
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02115
,
D02156
,
D03301
| 5件: DHFR DHFR, DHFR2, LTA, NR3C1, TNF 💬 | 72件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 107 |
184 | Methyl prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 43 43, 49, 96 |
185 | Methylprednisolone or Prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Methylprednisolone Methylprednisolone, Prednisolone | 14件: D00407
D00407
,
D00472
,
D00751
,
D00979
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
186 | Metoprolol Tartrate Oral Tablet | 1件: Metoprolol Metoprolol | 3件: D00601
D00601
,
D02358
,
D05011
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
187 | Metronidazole Oral | 1件: Metronidazole Metronidazole | 3件: D00409
D00409
,
D05016
,
D05017
| - | - | 1件: 96 96 |
188 | Microgynon® 30 (Oral contraceptive) | - | - | - | - | 1件: 46 46 |
189 | Mirdametinib (PD-0325901) oral capsule or dispersible tablet | 1件: PD-0325901 PD-0325901 | - | - | - | 1件: 34 34 |
190 | Modified Oral Glucose Tolerance Test (50g 4-hours) | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
191 | Mono-Therapy with Sildenafil (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
192 | MS-20 oral solution | - | - | - | - | 1件: 97 97 |
193 | Multi-modal pain management [Fentanyl] (Synonym: Oralet (TN)) | 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
(Name: Oralet (TN)) | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 |
194 | Mycophenolate mofetil orally 1000 mg twice a day (BID) | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 222 222 |
195 | Naproxen (Synonym: NAPROXEN ORAL SUSPENSION) | 1件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension) | 1件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION) | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 13 13, 46, 107, 271 |
196 | Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.) (Synonym: NAPROXEN ORAL SUSPENSION) | 1件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension) | 1件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION) | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
197 | Naproxen 10 mg/kg (Synonym: NAPROXEN ORAL SUSPENSION) | 1件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension) | 1件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION) | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
198 | Naproxen 500 mg tablets (PN 200 minus omeprazole) (Synonym: NAPROXEN ORAL SUSPENSION) | 2件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension), Omeprazole | 5件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION),
D00455
,
D01207
,
D05259
,
D05261
| 4件: ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | 26件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 46 46, 271 |
199 | Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.) (Synonym: NAPROXEN ORAL SUSPENSION) | 1件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension) | 1件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION) | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
200 | Naproxen oral suspension | 1件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension) | 1件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION) | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
201 | NAPROXEN SODIUM (Synonym: NAPROXEN ORAL SUSPENSION) | 1件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension) | 1件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION) | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 107 107 |
202 | Naproxen sodium 550mg tablet (Synonym: NAPROXEN ORAL SUSPENSION) | 1件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension) | 1件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION) | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
203 | Neoral Oral Solution | 1件: Cyclosporine Cyclosporine (Synonym: Sandimmune Oral Sol 100mg/ml) | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 269 269 |
204 | Nilotinib 150mg oral capsule [Tasigna] | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 |
205 | Nilotinib 300mg oral capsule [Tasigna] | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 |
206 | Nitazoxanide 500Mg Oral Tablet | 1件: Nitazoxanide Nitazoxanide | 1件: D02486
D02486
| - | - | 1件: 97 97 |
207 | NOXAFIL - 40 mg/ml oral suspension | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 299 299 |
208 | NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 299 299 |
209 | NOXAFIL - oral suspension 40 mg/ml | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 299 299 |
210 | Noxafil 40 mg/ml oral solution | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 65 65 |
211 | OC oral solution treatment A | - | - | - | - | 1件: 6 6 |
212 | OC oral solution treatment B | - | - | - | - | 1件: 6 6 |
213 | OC oral solution treatment C | - | - | - | - | 1件: 6 6 |
214 | OC oral solution treatment D | - | - | - | - | 1件: 6 6 |
215 | Okrido 6mg/mL oral solution | - | - | - | - | 1件: 3 3 |
216 | Oleovit D3 14.400 IU/ml oral drops, solution | - | - | - | - | 1件: 13 13 |
217 | Omadacycline Oral Tablet [Nuzyra] | 1件: Omadacycline Omadacycline | 1件: D09647
D09647
| - | - | 1件: 299 299 |
218 | Omeprazole 20 MG Oral Tablet | 1件: Omeprazole Omeprazole | 4件: D00455
D00455
,
D01207
,
D05259
,
D05261
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 98 98 |
219 | Optimized oral treatment | - | - | - | - | 1件: 6 6 |
220 | Oral | - | - | - | - | 2件: 46 46, 271 |
221 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone | 2件: Mesalazine Mesalazine, Methylprednisolone | 7件: D00377
D00377
,
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
222 | Oral all-trans retinoic acid (ATRA) | 1件: Tretinoin Tretinoin | 1件: D00094
D00094
| 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 94 94 |
223 | Oral anticoagulant treatment | - | - | - | - | 1件: 86 86 |
224 | Oral Aztreonam | 1件: Aztreonam Aztreonam | 2件: D00240
D00240
,
D06558
| - | - | 1件: 299 299 |
225 | Oral bovine type I collagen | 1件: Bovine type I collagen Bovine type I collagen | - | - | - | 1件: 51 51 |
226 | Oral bovine type II collagen | - | - | - | - | 1件: 46 46 |
227 | Oral Budesonide | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
228 | Oral Budesonide Suspension (MB-9) | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
229 | Oral Budesonide Suspension (OBS) | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
230 | Oral ciprofloxacin | 1件: Ciprofloxacin Ciprofloxacin (Synonym: Cipro Oral Suspension) | 2件: D00186
D00186
,
D02216
| - | - | 1件: 299 299 |
231 | Oral ciprofloxacin plus inhaled colistin | 2件: Ciprofloxacin Ciprofloxacin (Synonym: Cipro Oral Suspension), Colistin | 4件: D00186
D00186
,
D02138
,
D02216
,
D07746
| - | - | 1件: 299 299 |
232 | Oral corticosteroids | - | - | - | - | 4件: 13 13, 46, 97, 171 |
233 | Oral corticosteroids (OCS) | - | - | - | - | 1件: 162 162 |
234 | Oral cromolyn sodium | 1件: Cromoglicic acid Cromoglicic acid (Synonym: Cromolyn Sodium Oral Solution) | 2件: D00526
D00526
(Name: CROMOLYN SODIUM ORAL SOLUTION),
D07753
| - | - | 1件: 98 98 |
235 | Oral Cyclosporine | 1件: Cyclosporine Cyclosporine (Synonym: Sandimmune Oral Sol 100mg/ml) | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
236 | Oral drops solution | - | - | - | - | 1件: 28 28 |
237 | Oral ERA | - | - | - | - | 1件: 86 86 |
238 | Oral erythromycin | 1件: Erythromycin Erythromycin | 9件: D00140
D00140
,
D00851
,
D01361
,
D02009
,
D02184
,
D02523
,
D02524
,
D02525
,
D04054
| - | - | 1件: 36 36 |
239 | Oral escitalopram | 1件: Escitalopram Escitalopram | 3件: D02567
D02567
,
D07704
,
D07913
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
240 | Oral Glucose Tolerance Test | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
241 | Oral Glucose Tolerance test (75g 2-hour) | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
242 | Oral Glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
243 | Oral Ifetroban | 1件: Ifetroban Ifetroban | 1件: D04500
D04500
| 1件: TBXA2R TBXA2R 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | 2件: 51 51, 86 |
244 | Oral Iron | 1件: Iron Iron | - | - | - | 2件: 97 97, 254 |
245 | Oral levodopa and carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
246 | Oral Levodopa/Carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
247 | Oral LEVOSIMENDAN | 1件: Levosimendan Levosimendan | 1件: D04720
D04720
| 2件: PDE3A PDE3A, PDE3B 💬 | 11件: Apelin signaling pathway Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
248 | Oral lipoic acid (LA) | 1件: Lipoic acid Lipoic acid | 2件: D00048
D00048
,
D00086
| - | - | 1件: 13 13 |
249 | Oral methotrexate | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
250 | Oral Methylprednisolone 625 mg/24h x3 days | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
251 | Oral migalastat HCl | 1件: Migalastat Migalastat | 1件: D10359
D10359
| - | - | 1件: 19 19 |
252 | Oral nutritional supplementation | - | - | - | - | 1件: 2 2 |
253 | Oral OKT3 | - | - | - | - | 1件: 97 97 |
254 | Oral PDE5 inhibitors | - | - | - | - | 1件: 86 86 |
255 | Oral Pednisolone | - | - | - | - | 1件: 145 145 |
256 | Oral prednisolone | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 49 49, 96, 145 |
257 | Oral prednisone | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 251 251 |
258 | Oral Prednisone 5mg | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 |
259 | Oral probiotic | - | - | - | - | 1件: 291 291 |
260 | Oral reduced l-glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
261 | Oral roflumilast | 1件: Roflumilast Roflumilast | 1件: D05744
D05744
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 299 299 |
262 | Oral SCIO-469 capsule | - | - | - | - | 1件: 46 46 |
263 | Oral selexipag (Uptravi) | 1件: Selexipag Selexipag | 1件: D09994
D09994
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
264 | Oral sildenafil | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
265 | Oral sirolimus | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 278 278 |
266 | Oral THC | - | - | - | - | 1件: 13 13 |
267 | Oral treprostinil | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 2件: 51 51, 86 |
268 | Oral treprostinil (UT-15C) Sustained Release Tablets | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
269 | Oral Vancomycin | 1件: Vancomycin Vancomycin | 2件: D00212
D00212
,
D00926
| - | - | 2件: 94 94, 296 |
270 | Oral Viscous Budesonide | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
271 | Oral Viscous Budesonide (OVB) | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
272 | Orally disintegrating selegiline (Zelapar) | 1件: Selegiline Selegiline | 2件: D00785
D00785
,
D03731
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
273 | Orfadin oral suspension 4mg/ml | 1件: Nitisinone Nitisinone | 1件: D05177
D05177
| 1件: HPD HPD 💬 | 5件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 241 241 |
274 | Oseltamivir (Synonym: OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSION) | 1件: Oseltamivir Oseltamivir (Synonym: Oseltamivir Powder for Oral Suspension) | 2件: D00900
D00900
(Name: OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSION),
D08306
| - | - | 2件: 97 97, 299 |
275 | OTEZLA - 10 MG + 20 MG + 30 MG COMPRESSA RIVESTITA CON FILM USO ORALE - BLISTER (PVC/ALU) IN UN ASTUCCIO - 4 COMPRESSE DA 10 MG + 4 COMPRESSE DA 20 MG +19 COMPRESSE DA 30 MG | 1件: Apremilast Apremilast | 1件: D08860
D08860
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 |
276 | OTEZLA - 30 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/ALU) - 56 COMPRESSE | 1件: Apremilast Apremilast | 1件: D08860
D08860
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 107 107 |
277 | Other: Functional Oral Intake Scale | - | - | - | - | 1件: 2 2 |
278 | Other: Metformin (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 1件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution) | 2件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 46 46 |
279 | Other: Modified Oral Glucose Tolerance Test | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 65 65 |
280 | Other: Oral Glucose tolerance test | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 3件: 160 160, 195, 299 |
281 | Other: Oral Glucose Tolerance Test (OGTT) assessment arm | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
282 | Other: Oral Nitric Oxide testing | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 1件: 98 98 |
283 | Other: standard immune suppression, oral | - | - | - | - | 1件: 228 228 |
284 | Other: Standard of Care Sildenafil (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 90 90, 301 |
285 | Overencapsulated Prednisolone Tablets (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
286 | Paracetamol 120Mg/5mL Oral Suspension | 1件: Acetaminophen Acetaminophen (Synonym: Isometheptene-Dichloral-APAP Oral) | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 3 3 |
287 | Paroxetine & Prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Paroxetine Paroxetine, Prednisolone | 12件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D02260
,
D02362
,
D03301
,
D05374
,
D05375
| 2件: NR3C1 NR3C1, SLC6A4 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 |
288 | Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Paroxetine Paroxetine, Prednisolone | 12件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D02260
,
D02362
,
D03301
,
D05374
,
D05375
| 2件: NR3C1 NR3C1, SLC6A4 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 |
289 | Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Paroxetine Paroxetine, Prednisolone | 12件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D02260
,
D02362
,
D03301
,
D05374
,
D05375
| 2件: NR3C1 NR3C1, SLC6A4 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 |
290 | Part I- naproxen 1000 mg (Synonym: NAPROXEN ORAL SUSPENSION) | 1件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension) | 1件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION) | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 |
291 | Part II- naproxen 1000 mg (Synonym: NAPROXEN ORAL SUSPENSION) | 1件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension) | 1件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION) | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 |
292 | PEG-liposomal Prednisolone Sodium Phosphate (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Phosphate ion Phosphate ion, Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 97 |
293 | Phenylbutyrate Oral Tablet | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 1件: 15 15 |
294 | Pioglitazone or metformin (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 2件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution), Pioglitazone | 4件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D00945
,
D04966
,
D08378
| 3件: PPARG PPARG, PRKAA1, PRKAA2 💬 | 27件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 1件: 265 265 |
295 | Pitolisant Oral Tablet | 1件: Pitolisant Pitolisant | 1件: D10749
D10749
| 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 |
296 | Pitolisant oral tablets | 1件: Pitolisant Pitolisant | 1件: D10749
D10749
| 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 193 193 |
297 | PN 200 tablets (500 mg naproxen and 20 mg omeprazole) (Synonym: NAPROXEN ORAL SUSPENSION) | 2件: Naproxen Naproxen (Synonym: Naproxen Oral Suspension), Omeprazole | 5件: D00118
D00118
(Name: NAPROXEN ORAL SUSPENSION),
D00455
,
D01207
,
D05259
,
D05261
| 4件: ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | 26件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 46 46, 271 |
298 | Pomalidomide Oral Product | 1件: Pomalidomide Pomalidomide | 1件: D08976
D08976
| 2件: IL6 IL6, TNF 💬 | 80件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 227 227 |
299 | Posaconazole Delayed Release Oral Tablet | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 96 96 |
300 | Powder for Oral Suspension) | - | - | - | - | 1件: 113 113 |
301 | Predinose oral | - | - | - | - | 1件: 70 70 |
302 | PREDNISOLONE (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
303 | Prednisolone & dipyridamole (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Dipyridamole Dipyridamole, Prednisolone | 9件: D00302
D00302
,
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 3件: NR3C1 NR3C1, PDE4A, PDE5A 💬 | 7件: Metabolic pathways Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
304 | Prednisolone + mabthera (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Prednisolone Prednisolone, Rituximab | 9件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D02994
,
D03301
| 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 |
305 | Prednisolone 1mg Tablets (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
306 | Prednisolone 2,5 mg Tablets (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
307 | Prednisolone 20 mg (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
308 | Prednisolone 40 mg (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
309 | Prednisolone 5 mg (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 51 |
310 | Prednisolone 5 mg JENAPHARM (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 |
311 | Prednisolone 5 mg Tablets (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
312 | Prednisolone 5mg Gastro-resistant Tablets (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 |
313 | Prednisolone 5mg Tablet (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
314 | PREDNISOLONE ACETATE (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 3件: Acetate Acetate, Prednisolone, Prednisolone acetate | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 |
315 | Prednisolone and chlorambucil (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Chlorambucil Chlorambucil, Prednisolone | 9件: D00266
D00266
,
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 |
316 | Prednisolone and mycophenolate mofetil (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 3件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid, Prednisolone | 12件: D00472
D00472
,
D00752
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
,
D05094
,
D05095
,
D05096
| 3件: IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | 1件: 222 222 |
317 | Prednisolone and taper (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 |
318 | Prednisolone Labesfal (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
319 | Prednisolone sodium metasulphobenzoate (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
320 | PREDNISOLONE SODIUM PHOSPHATE (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Phosphate ion Phosphate ion, Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 3 3, 13, 97 |
321 | PREDNISOLONE SODIUM SUCCINATE (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 95 95 |
322 | Prednisolone Tablets B.P. 5mg (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
323 | Prednisolone Tablets BP (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
324 | Prednisolone Tablets BP 1 mg (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
325 | Prednisolone Tablets USP 5 mg (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
326 | Prednisolone-Dipyridamole (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Dipyridamole Dipyridamole, Prednisolone | 9件: D00302
D00302
,
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 3件: NR3C1 NR3C1, PDE4A, PDE5A 💬 | 7件: Metabolic pathways Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
327 | Prednisolone/Prednisone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Prednisolone Prednisolone, Prednisone | 9件: D00472
D00472
,
D00473
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 |
328 | Prednisone 0,5 mg/kg orally on alternate days | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 |
329 | Prednisone or Prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Prednisolone Prednisolone, Prednisone | 9件: D00472
D00472
,
D00473
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 66 66, 84 |
330 | Prednisone/Prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Prednisolone Prednisolone, Prednisone | 9件: D00472
D00472
,
D00473
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 |
331 | Pyridoxine plus prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Prednisolone Prednisolone, Pyridoxine (Synonym: Poly-Vite/Iron Oral Solution) | 10件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D02179
,
D03301
,
D08454
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 145 145 |
332 | RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE | 1件: Ranolazine Ranolazine | 2件: D05700
D05700
,
D05701
| - | - | 1件: 58 58 |
333 | RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 2 2 |
334 | RAPAMUNE 1 mg/ml oral solution | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 158 158 |
335 | Rapamune 1 mg/ml solución oral | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 158 158 |
336 | RAXONE - 150 MG- COMPRESSE RIVESTITE CON FILM- USO ORALE- FLACONE (HDPE)- 180 COMPRESSE | 1件: Idebenone Idebenone | 1件: D01750
D01750
| - | - | 1件: 113 113 |
337 | Revatio 10 mg/ml powder for oral suspension | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
338 | Revatio oral | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
339 | REVOLADE - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU) 28 COMPRESSE | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 60 60 |
340 | REVOLADE - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 60 60 |
341 | Rifaximin oral tablet | 1件: Rifaximin Rifaximin | 1件: D02554
D02554
| - | - | 1件: 99 99 |
342 | Rigosertib Oral Capsules / Rigosertib Intravenous | 1件: Rigosertib Rigosertib | 1件: D10154
D10154
| 1件: PLK1 PLK1 💬 | 4件: Cell cycle Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 36 36 |
343 | Riluzole Oral Soluble Film | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
344 | Riluzole Oral Soluble film (ROSF) 50 mg | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
345 | Rilzabrutinib Oral Tablet | - | - | - | - | 1件: 35 35 |
346 | Riociguat granules 0.3% for oral application | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
347 | Riociguat Oral Product | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
348 | Riociguat Oral Tablet | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 88 88 |
349 | Risedronate Oral Tablet | 1件: Risedronic acid Risedronic acid | 3件: D00942
D00942
,
D03234
,
D08484
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 |
350 | Roflumilast Oral Tablet | 1件: Roflumilast Roflumilast | 1件: D05744
D05744
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 299 299 |
351 | Ropinirole oral product | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
352 | Rufinamide oral suspension | 1件: Rufinamide Rufinamide | 1件: D05775
D05775
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 144 144 |
353 | SABRIL 500 mg, granules for oral solution | 1件: Vigabatrin Vigabatrin (Synonym: Vigabatrin for Oral Solution) | 1件: D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION) | 1件: ABAT ABAT 💬 | 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 158 158 |
354 | Sabril granules for oral use | 1件: Vigabatrin Vigabatrin (Synonym: Vigabatrin for Oral Solution) | 1件: D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION) | 1件: ABAT ABAT 💬 | 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 145 145 |
355 | Saccharomyces Boulardii Oral Tablet | 1件: Saccharomyces cerevisiae Saccharomyces cerevisiae | - | - | - | 1件: 51 51 |
356 | Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet | 2件: Salbutamol Salbutamol (Synonym: Ventolin Oral Liquid), Sulfate ion | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 111 111 |
357 | Salbutamol Only Product in Oral Dose Form | 1件: Salbutamol Salbutamol (Synonym: Ventolin Oral Liquid) | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 111 111 |
358 | SAMSCA 7.5 mg oral tablet | 1件: Tolvaptan Tolvaptan | 1件: D01213
D01213
| 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 |
359 | SB-681323 oral tablets | - | - | - | - | 1件: 46 46 |
360 | Semi continuous intra-oral administration of LD/CD | - | - | - | - | 1件: 6 6 |
361 | Sevelamer (Synonym: SEVELAMER CARBONATE FOR ORAL SUSPENSION) | 1件: Sevelamer Sevelamer (Synonym: Sevelamer Carbonate for Oral Suspension) | 3件: D01983
D01983
,
D06642
(Name: SEVELAMER CARBONATE FOR ORAL SUSPENSION),
D08512
| - | - | 2件: 235 235, 238 |
362 | Sildenafil (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
363 | Sildenafil (50 mg) (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 85 85 |
364 | Sildenafil (Acute-1 hour) (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
365 | Sildenafil (as citrate) (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
366 | Sildenafil (REVATIO) (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
367 | Sildenafil (Revatio) 20 mg TID (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
368 | Sildenafil (Subchronic-4 weeks) (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
369 | Sildenafil 20 mg tablets (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 278 278 |
370 | Sildenafil 20mg (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 |
371 | Sildenafil 20mg and Bosentan 62.5mg (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 2件: Bosentan Bosentan, Sildenafil (Synonym: Sildenafil for Oral Suspension) | 4件: D01227
D01227
,
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D07538
,
D08514
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 |
372 | Sildenafil 40mg oral capsule | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
373 | Sildenafil and Losartan (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 2件: Losartan Losartan, Sildenafil (Synonym: Sildenafil for Oral Suspension) | 4件: D00357
D00357
,
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08146
,
D08514
| 2件: AGTR1 AGTR1, PDE5A 💬 | 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 85 85 |
374 | Sildenafil by injection (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 210 210 |
375 | Sildenafil citrate (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 4件: 51 51, 85, 86, 225 |
376 | Sildenafil citrate (UK-92,480) (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
377 | Sildenafil Filmtabletten (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
378 | Sildenafil singly or in association with Bosentan (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 2件: Bosentan Bosentan, Sildenafil (Synonym: Sildenafil for Oral Suspension) | 4件: D01227
D01227
,
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D07538
,
D08514
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
379 | Sildenafil therapy (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 1件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 51 51 |
380 | Simvastatin 20mg/5ml Oral Suspension | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 34 34 |
381 | Sinemet 25-100 Oral Tablet | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
382 | Sirolimus Oral Liquid Product 1mg/mL | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 278 278 |
383 | Sirolimus Oral Product | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 2件: 89 89, 158 |
384 | Sitagliptin and Metformin (Synonym: METFORMIN HYDROCHLORIDE ORAL SOLUTION) | 2件: Metformin Metformin (Synonym: Metformin Hydrochloride Oral Solution), Sitagliptin | 3件: D00944
D00944
(Name: METFORMIN HYDROCHLORIDE ORAL SOLUTION),
D04966
,
D08516
| 3件: DPP4 DPP4, PRKAA1, PRKAA2 💬 | 21件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 233 233 |
385 | Sitaxsentan and Sildenafil (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 2件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension), Sitaxentan | 3件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D07171
,
D08514
| 2件: EDNRA EDNRA, PDE5A 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
386 | Sodium phosphate enema, oral rifaximin and polyethylene glycol | 3件: Phosphate ion Phosphate ion, Polyethylene glycol, Rifaximin | 2件: D02554
D02554
,
D03370
| - | - | 1件: 6 6 |
387 | Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 2件: Dextrose, unspecified form Dextrose, unspecified form, Sildenafil (Synonym: Sildenafil for Oral Suspension) | 2件: D02229
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
388 | SOLUBLE PREDNISOLONE TABLETS (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 145 145 |
389 | Sporanox 10 mg/ml Oral Solution | 1件: Itraconazole Itraconazole (Synonym: Sporanox Oral Solution 10mg/ml) | 1件: D00350
D00350
| - | - | 1件: 299 299 |
390 | Standard analgesia use [Fentanyl] (Synonym: Oralet (TN)) | 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
(Name: Oralet (TN)) | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 |
391 | Sulphasalazine + Hydroxychloroquine OR Prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Hydroxychloroquine Hydroxychloroquine, Prednisolone | 9件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
,
D08050
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
392 | Sustained-release oral dalfampridine | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
393 | Tadalafil and Sildenafil (Synonym: SILDENAFIL FOR ORAL SUSPENSION) | 2件: Sildenafil Sildenafil (Synonym: Sildenafil for Oral Suspension), Tadalafil | 3件: D02008
D02008
,
D02229
(Name: SILDENAFIL FOR ORAL SUSPENSION),
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 113 113 |
394 | Tadalafil oral suspension | 1件: Tadalafil Tadalafil | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
395 | Tadalafil- Tablet or Oral suspension | 1件: Tadalafil Tadalafil | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
396 | TECFIDERA - 240 MG - CAPSULA RIGIDA GASTRORESISTENTE - USO ORALE - BLISTER (PVC/PE/PVDC-PVC ALLUMINIO) - 56 CAPSULE | - | - | - | - | 1件: 13 13 |
397 | Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. | 1件: Teicoplanin Teicoplanin | 1件: D02142
D02142
| - | - | 1件: 299 299 |
398 | TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY] | 2件: Tenofovir Tenofovir, Tenofovir alafenamide | 2件: D06074
D06074
,
D10428
| - | - | 1件: 13 13 |
399 | Teriflunomide 14 MG Oral Tablet [Aubagio] | 1件: Teriflunomide Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 |
400 | THALIDOMIDE CELGENE - 50 MG CAPSULA RIGIDA - USO ORALE - BLISTER (PVC/PE/ACLAR/ALU) 28 CAPSULE | 1件: Thalidomide Thalidomide | 1件: D00754
D00754
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
401 | Tizanidine (sublingual or oral) | 1件: Tizanidine Tizanidine | 2件: D00776
D00776
,
D08611
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 |
402 | Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial | 1件: Tofacitinib Tofacitinib | 1件: D09970
D09970
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 84 84 |
403 | Tolvaptan Oral Tablet | 1件: Tolvaptan Tolvaptan | 1件: D01213
D01213
| 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 72 72 |
404 | Transdermal fentanyl matrix, gabapentin (Synonym: Oralet (TN)) | 2件: Fentanyl Fentanyl, Gabapentin | 3件: D00320
D00320
,
D00332
,
D01399
(Name: Oralet (TN)) | 6件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬 | 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 70 70 |
405 | Translarna 1000 mg granules for oral suspension | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 113 113 |
406 | Translarna 125 mg granules for oral suspension | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 113 113 |
407 | Translarna 250 mg granules for oral suspension | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 113 113 |
408 | Trazodone Hydrochloride oral solution | 1件: Trazodone Trazodone | 2件: D00820
D00820
,
D08626
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 2 2 |
409 | Trexan+Salazopyrin+Oxiklorin+prednisolone (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
410 | Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Infliximab Infliximab, Prednisolone | 9件: D00472
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D02598
,
D03301
| 2件: NR3C1 NR3C1, TNF 💬 | 68件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
411 | Triamcinolone (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 35 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 |
412 | Triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip) (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
413 | Triamcinolone Acetonide (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 35 35, 46, 56 |
414 | Triamcinolone Acetonide and normal saline solution (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 |
415 | Triamcinolone hexacetonid (Lederspan) (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
416 | Triamcinolone hexacetonide (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 107 |
417 | Triamcinolone hexacetonide (Lederspan) (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
418 | Triamcinolone Hexacetonide 20 MG/ML (Synonym: ORALONE) | 1件: Triamcinolone Triamcinolone (Synonym: Oralone) | 5件: D00385
D00385
,
D00983
(Name: ORALONE),
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 107 107 |
419 | Vamorolone 4% suspension for oral dosing | 1件: Vamorolone Vamorolone | 1件: D11000
D11000
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
420 | Ventoline oral solution 0,4mg/ml | - | - | - | - | 1件: 111 111 |
421 | VFEND 40 mg/ml powder for oral suspension | 1件: Voriconazole Voriconazole | 1件: D00578
D00578
| - | - | 1件: 299 299 |
422 | VIGABATRIN (Synonym: VIGABATRIN FOR ORAL SOLUTION) | 1件: Vigabatrin Vigabatrin (Synonym: Vigabatrin for Oral Solution) | 1件: D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION) | 1件: ABAT ABAT 💬 | 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 2件: 145 145, 158 |
423 | Vigabatrin (Sabril) (Synonym: VIGABATRIN FOR ORAL SOLUTION) | 1件: Vigabatrin Vigabatrin (Synonym: Vigabatrin for Oral Solution) | 1件: D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION) | 1件: ABAT ABAT 💬 | 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 158 158 |
424 | Vigabatrin Tablets (Synonym: VIGABATRIN FOR ORAL SOLUTION) | 1件: Vigabatrin Vigabatrin (Synonym: Vigabatrin for Oral Solution) | 1件: D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION) | 1件: ABAT ABAT 💬 | 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 145 145 |
425 | Vigabatrin: Vigabatrin new ST formulation then Sabril® (Synonym: VIGABATRIN FOR ORAL SOLUTION) | 1件: Vigabatrin Vigabatrin (Synonym: Vigabatrin for Oral Solution) | 1件: D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION) | 1件: ABAT ABAT 💬 | 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 145 145 |
426 | VIREAD - 245 MG 30 COMPRESSE RIVESTITE CON FILM IN FLACONE USO ORALE | - | - | - | - | 1件: 46 46 |
427 | XADAGO - 100 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
428 | XADAGO - 50 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
429 | Z102 (Prednisolone and Dipyridamole). (Synonym: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION) | 2件: Dipyridamole Dipyridamole, Prednisolone | 9件: D00302
D00302
,
D00472
,
D00980
,
D00981
(Name: PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION),
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 3件: NR3C1 NR3C1, PDE4A, PDE5A 💬 | 7件: Metabolic pathways Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
430 | ZYTIGA - 250 MG - COMPRESSA - USO ORALE - FLACONE 120 COMPRESSE | 1件: Abiraterone Abiraterone | - | - | - | 1件: 75 75 |